Study guide
3.3 Iontophoresis Biophysics, Pharmacology & Dosing Protocols
NBCE Physiotherapy Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Clinical Foundations, Healing Physiology & Scope of Practice
1.1 NBCE Physiotherapy Examination & Scope of Practice 1.2 Tissue Healing Phases & Biological Repair Mechanisms 1.3 Pain Neurophysiology & Pain Modulation Theories
2 Chapter 2: Electrotherapy Foundations & Pain Modulation Modalities
2.1 Principles of Electricity, Waveforms & Current Density 2.2 Transcutaneous Electrical Nerve Stimulation (TENS) Modes & Protocols 2.3 Interferential Current (IFC) & Premodulated Current Therapy
3 Chapter 3: Neuromuscular Stimulation & Advanced Electrotherapy Modalities
3.1 Neuromuscular Electrical Stimulation (NMES) & Russian Stimulation 3.2 High-Voltage Pulsed Current (HVPC) & Microcurrent Electrical Therapy 3.3 Iontophoresis Biophysics, Pharmacology & Dosing Protocols
4 Chapter 4: Thermal Modalities — Cryotherapy & Superficial Heat
4.1 Cryotherapy Biophysics, Hunting Reaction & Clinical Protocols 4.2 Superficial Heat: Hydrocollator Moist Packs & Paraffin Bath 4.3 Fluidotherapy & Radiant Infrared Heat Modalities
5 Chapter 5: Therapeutic Ultrasound, Phonophoresis & Deep Heat
5.1 Ultrasound Biophysics, Frequency Selection & Beam Metrics (BNR & ERA) 5.2 Thermal vs. Non-Thermal Ultrasound & Treatment Parameters 5.3 Phonophoresis Protocols & Ultrasound-Electrotherapy Combination
6 Chapter 6: Mechanotherapy — Traction, Soft Tissue, Bracing & Taping
6.1 Cervical Mechanical Traction: Angles, Force Parameters & Protocols 6.2 Lumbar Mechanical Traction: Positioning, Force & Table Dynamics 6.3 Intermittent Pneumatic Compression, CPM & Mechanotherapy 6.4 Therapeutic Massage, Vibration & Trigger Point Therapy 6.5 Bracing & Orthotic Prescription 6.6 Therapeutic Taping: Rigid, McConnell & Elastic Techniques
7 Chapter 7: Hydrotherapy & Phototherapy (Light Therapy)
7.1 Hydrotherapy Principles, Whirlpool Therapy & Contrast Baths 7.2 Low-Level Laser Therapy (Photobiomodulation) & Biophysics 7.3 Ultraviolet Therapy (UVA/UVB) & Radiant Infrared Therapy
8 Chapter 8: Functional Assessment, Exercise Physiology & Muscle Rehabilitation
8.1 Exercise Physiology Foundations: Bioenergetics, Fiber Types & Muscle Contractions 8.2 Range of Motion, Therapeutic Stretching & PNF Techniques 8.3 Postural Syndromes, Janda's Classifications & Functional Movement Assessment 8.4 Gait Cycle Analysis & Pathological Gait Patterns 8.5 Neurobiology of Training: Motor Unit Recruitment, Neural Adaptation & Motor Learning 8.6 Strengthening: Progressive Resistance Exercise & Loading Prescription
9 Chapter 9: Neuromuscular Rehabilitation — Balance, Motor Control & Spine Stabilization
9.1 Spinal Stabilization Mechanics & Stuart McGill's Core Protocols 9.2 Cervical Spine Rehabilitation: Radiculopathy, Whiplash & Postural Syndromes 9.3 Lumbar Spine Rehabilitation: Disc Herniation, Stenosis & Spondylolisthesis 9.4 Balance, Postural Alignment & Sensorimotor Training 9.5 Coordinated Movement Patterns & Motor Control Retraining 9.6 Sacroiliac Joint & Pelvic Girdle Rehabilitation
10 Chapter 10: Extremity Rehabilitation, Clinical Safety & CPT Documentation
10.1 Upper Extremity Rehabilitation: Rotator Cuff, Impingement, Epicondylalgia & Carpal Tunnel 10.2 Lower Extremity Rehabilitation: Patellofemoral Pain, ACL, Achilles Tendinopathy & Plantar Fasciitis 10.3 Universal Modality Contraindications, Safety Screening & Red Flags 10.4 Physical Medicine CPT Coding (97000 Series), 8-Minute Rule & SOAP Documentation
11 Chapter 11: Endurance Training & Cardiovascular Rehabilitation
11.1 Aerobic Capacity, VO2max & Cardiorespiratory Adaptation 11.2 Aerobic Exercise Prescription: FITT-VP, Intensity Monitoring & Progression 11.3 Cardiovascular Rehabilitation: Risk Stratification, Phases & Safety Limits
3.3 Iontophoresis Biophysics, Pharmacology & Dosing Protocols
Key Takeaways Explain This Topic AI
Iontophoresis utilizes continuous low-voltage Direct Current (DC) to drive ionized medications transdermally into local tissues via electrostatic repulsion (like charges repel: negative ions from cathode, positive ions from anode).
Clinical dosage is governed by the formula Dosage (mA·min) = Current Amplitude (mA) × Treatment Time (min); standard therapeutic dosage is 40 mA·min (range 40–80 mA·min), with lower amplitudes (e.g., 2.0 mA for 20 min) reducing skin irritation.
Maximum safe current density limits are 0.5 mA/cm² for the cathode and 1.0 mA/cm² for the anode; the cathodal limit is twice as conservative because water reduction forms sodium hydroxide (NaOH), which causes destructive liquefaction necrosis.
Core clinical pharmacological agents include dexamethasone sodium phosphate (negative/cathode) for acute inflammatory bursitis/tendinitis, lidocaine hydrochloride (positive/anode) for local anesthesia, and acetic acid (negative/cathode) for calcific tendinitis.
Mandatory pre- and post-treatment skin inspection is required to distinguish expected transient galvanic erythema (capillary vasodilation) from adverse electrochemical burns or ulcerations.
Last updated: September 2026
3.3 Iontophoresis Biophysics, Pharmacology & Dosing Protocols
Iontophoresis is the transdermal delivery of topically applied, chemically ionized pharmacological agents driven into local target tissues using low-voltage continuous Direct Current (DC) . In physical medicine and chiropractic rehabilitation, iontophoresis provides a targeted, non-invasive, localized alternative to systemic oral medication or hypodermic corticosteroid injections, bypassing hepatic first-pass metabolism and minimizing systemic side effects.
- Biophysical Principles of Iontophoresis
- Electrostatic Repulsion (Coulomb's Law)
The biophysical principle driving iontophoresis is electrostatic repulsion : like electrical charges repel one another, while opposite charges attract.
An ionized pharmacological agent carries a specific net valence charge in aqueous solution.
When placed beneath an active treatment electrode of the same polarity , the electrical potential of the electrode repels the ionic molecules, driving them electrostatically through the epidermis:
Negatively charged drugs (anions) are placed beneath the Cathode (negative electrode) .
Positively charged drugs (cations) are placed beneath the Anode (positive electrode) .
Transdermal Transport Pathways
The human stratum corneum is a formidable lipophilic barrier characterized by high electrical resistance. Direct current drives ionic medication primarily through cutaneous pathways of least resistance:
Skin Appendages (Shunt Pathways) : Sweat gland ducts (eccrine glands) and hair follicles / sebaceous units account for the majority of initial ion penetration.
Intercellular Lipid Pathways : The continuous electric field temporarily increases skin permeability by disrupting intercellular lipid bilayer packing ( electroporation ), enabling deeper molecular transit into the vascularized dermis and underlying connective tissue (typically reaching depths of 1 to 5 mm).
Electrode Setup
Active (Delivery) Electrode : Saturated with the ionized pharmacological solution and placed directly over the target pathology.
Dispersive (Return) Electrode : A moist saline pad placed several inches away (typically a minimum of 4 to 6 inches) on healthy skin over a large muscle mass to complete the DC circuit without causing high local current concentration.
Dosing Calculations & Treatment Parameters
Iontophoretic drug delivery is strictly quantified in milliampere-minutes (mA·min) , representing the total electrical charge delivered to the tissue.
The Dosing Formula Dosage ( mA ⋅ min ) = Current Amplitude ( mA ) × Treatment Time ( min ) \text{Dosage } (\text{mA}\cdot\text{min}) = \text{Current Amplitude } (\text{mA}) \times \text{Treatment Time } (\text{min}) Dosage ( mA ⋅ min ) = Current Amplitude ( mA ) × Treatment Time ( min )
Standard Clinical Dosage
Standard Therapeutic Target : 40 mA·min is the gold standard therapeutic dose for the vast majority of musculoskeletal inflammatory conditions.
Acceptable Clinical Range : 40 to 80 mA·min depending on anatomical depth, skin tolerance, and drug concentration.
Mathematical Equivalency and Amplitude Selection
A standard 40 mA·min dose can mathematically be achieved through multiple combinations:
4.0 mA × 10 minutes = 40 mA ⋅ min 4.0\text{ mA} \times 10\text{ minutes} = 40\text{ mA}\cdot\text{min} 4.0 mA × 10 minutes = 40 mA ⋅ min
3.0 mA × 13.3 minutes = 40 mA ⋅ min 3.0\text{ mA} \times 13.3\text{ minutes} = 40\text{ mA}\cdot\text{min} 3.0 mA × 13.3 minutes = 40 mA ⋅ min
2.0 mA × 20 minutes = 40 mA ⋅ min 2.0\text{ mA} \times 20\text{ minutes} = 40\text{ mA}\cdot\text{min} 2.0 mA × 20 minutes = 40 mA ⋅ min
1.0 mA × 40 minutes = 40 mA ⋅ min 1.0\text{ mA} \times 40\text{ minutes} = 40\text{ mA}\cdot\text{min} 1.0 mA × 40 minutes = 40 mA ⋅ min
0.1 mA × 400 minutes = 40 mA ⋅ min 0.1\text{ mA} \times 400\text{ minutes} = 40\text{ mA}\cdot\text{min} 0.1 mA × 400 minutes = 40 mA ⋅ min (low-current, battery-powered wearable patch worn over 12–24 hours)
The Clinical Trade-Off: High vs. Low Amplitude
While delivering 4.0 mA 4.0\text{ mA} 4.0 mA for 10 minutes saves clinical time, it generates substantially greater skin resistance heating and carries a heightened risk of electrochemical burns. Operating at 2.0 mA 2.0\text{ mA} 2.0 mA for 20 minutes (or utilizing low-amplitude wearable patches) is clinically preferable: it significantly enhances patient comfort, preserves skin barrier integrity, and allows deeper, more uniform transdermal drug dispersion.
Current Density & Electrochemical Skin Reactions
Because continuous direct current maintains uninterrupted unidirectional electron flow, electrochemical electrolysis of water occurs beneath both electrodes, creating distinct chemical environments.
Current Density Limits
Current density determines the concentration of electrical current per unit area of the electrode surface: Current Density ( mA/cm 2 ) = Current Amplitude ( mA ) Conductive Electrode Surface Area ( cm 2 ) \text{Current Density } (\text{mA/cm}^2) = \frac{\text{Current Amplitude } (\text{mA})}{\text{Conductive Electrode Surface Area } (\text{cm}^2)} Current Density ( mA/cm 2 ) = Conductive Electrode Surface Area ( cm 2 ) Current Amplitude ( mA )
To prevent thermal and chemical skin damage, clinicians must adhere to strict maximum safe current density limits :
- Cathode (Negative Active Electrode) : Maximum 0.5 mA/cm 2 0.5\text{ mA/cm}^2 0.5 mA/cm 2
- Anode (Positive Active Electrode) : Maximum 1.0 mA/cm 2 1.0\text{ mA/cm}^2 1.0 mA/cm 2
- Electrochemical Water Hydrolysis: The Danger of Liquefaction Necrosis
When continuous direct current flows through tissue water, water molecules undergo oxidation at the anode and reduction at the cathode:
1. Cathodal Reaction (Reduction → \to → Alkaline Reaction): 2 H 2 O + 2 e − → H 2 ↑ + 2 OH − 2\text{H}_2\text{O} + 2\text{e}^- \to \text{H}_2\uparrow + 2\text{OH}^- 2 H 2 O + 2 e − → H 2 ↑ + 2 OH −
The newly formed hydroxide ions ( OH − \text{OH}^- OH − ) bind with tissue sodium cations ( Na + \text{Na}^+ Na + ) to produce Sodium Hydroxide ( NaOH \text{NaOH} NaOH ) beneath the cathode.
Liquefaction Necrosis : NaOH \text{NaOH} NaOH is an aggressive alkaline caustic agent. It hydrolyzes cellular proteins, saponifies membrane fatty acids, and dissolves extracellular matrix structures. Because liquefied tissue offers little mechanical barrier, the alkaline burn can penetrate deeply into the dermis and subcutaneous tissue, producing painful, slowly healing, crater-like chemical ulcerations.
2. Anodal Reaction (Oxidation → \to → Acidic Reaction): 2 H 2 O → O 2 ↑ + 4 H + + 4 e − 2\text{H}_2\text{O} \to \text{O}_2\uparrow + 4\text{H}^+ + 4\text{e}^- 2 H 2 O → O 2 ↑ + 4 H + + 4 e −
The newly formed hydrogen ions ( H + \text{H}^+ H + ) bind with tissue chloride anions ( Cl − \text{Cl}^- Cl − ) to produce Hydrochloric Acid ( HCl \text{HCl} HCl ) beneath the anode.
Coagulation Necrosis : HCl \text{HCl} HCl causes an acidic chemical reaction that denatures and coagulates tissue proteins, forming a dry, hardened scab ( eschar ). This coagulum forms a self-limiting physical barrier that restricts deeper acid penetration.
Why the Cathode Limit is Twice as Strict ( 0.5 0.5 0.5 vs. 1.0 mA/cm 2 1.0\text{ mA/cm}^2 1.0 mA/cm 2 )
Because the alkaline liquefaction necrosis produced beneath the cathode is substantially more corrosive, deeply invasive, and damaging than the self-limiting coagulation necrosis formed beneath the anode, the safe current density limit for the cathode ( 0.5 mA/cm 2 0.5\text{ mA/cm}^2 0.5 mA/cm 2 ) is set at half that of the anode ( 1.0 mA/cm 2 1.0\text{ mA/cm}^2 1.0 mA/cm 2 ).
Skin Inspection & Transient Galvanic Erythema
Normal Response : Following treatment, the skin beneath both electrodes will typically present with uniform pink erythema. This is a normal, benign physiological vasodilation mediated by local axon reflexes and histamine release in response to direct current. It typically resolves within 1 to 2 hours.
Abnormal Burn : The presence of localized grayish-white blanching, blisters (vesicles), pinpoint black crusts, or skin erosion indicates a chemical burn requiring immediate cessation of treatment, neutralization, and wound care.
Comprehensive Iontophoresis Pharmacopeia
Pharmacological Agent Ionic Charge Active Electrode (Polarity) Standard Concentration Physiological Mechanism Clinical Indications
Dexamethasone Sodium Phosphate Negative ( − - − ) Cathode ( − - − ) 0.4% solution Synthetic corticosteroid; inhibits phospholipase A 2 A_2 A 2 , blocks prostaglandin and leukotriene synthesis Acute subacromial bursitis, lateral/medial epicondylitis, bicipital tendinitis, plantar fasciitis
Lidocaine Hydrochloride Positive ( + + + ) Anode ( + + + ) 2% to 4% solution Local anesthetic; blocks voltage-gated fast N a + Na^+ N a + channels along sensory nerve axons, blocking pain transmission Acute localized soft tissue pain, superficial trigger points, acute post-traumatic contusions
Acetic Acid Negative ( − - − ) Cathode ( − - − ) 2% to 5% solution Supplies acetate ions ( CH 3 COO − \text{CH}_3\text{COO}^- CH 3 COO − ) that convert insoluble calcium carbonate/phosphate deposits into highly soluble calcium acetate Calcific tendinitis of the rotator cuff (supraspinatus), myositis ossificans
Potassium Iodide Negative ( − - − ) Cathode ( − - − ) 10% solution or ointment Sclerolytic agent; hydrolyzes dense collagen cross-links, softens scar tissue, and promotes tissue elasticity Hypertrophic scars, keloids, dense postoperative adhesions, adhesive capsulitis
Calcium Chloride Positive ( + + + ) Anode ( + + + ) 1% to 2% solution Calcium ions stabilize motor endplate membranes, decreasing peripheral neuromuscular excitability Chronic skeletal muscle spasms, myalgia, tetanic muscular guarding
Sodium Salicylate Negative ( − - − ) Cathode ( − - − ) 2% to 3% solution Non-steroidal salicylate; inhibits cyclooxygenase (COX), reducing inflammatory prostaglandins Acute localized joint inflammation, rheumatoid flare-ups, plantar fasciitis
Zinc Oxide Positive ( + + + ) Anode ( + + + ) 20% ointment or 0.1%–0.5% ZnSO 4 \text{ZnSO}_4 ZnSO 4 Antiseptic and astringent; accelerates epithelialization and stimulates fibroblast collagen cross-linking Chronic ischemic dermal ulcers, non-healing wounds, superficial excoriations
Tap Water Neutral / Polarity variable Anode / Cathode (alternating) Pure tap water Forms microscopic keratin plugs within eccrine sweat gland lumens via electro-osmosis Severe palmar, plantar, or axillary hyperhidrosis
Magnesium Sulfate Positive ( + + + ) Anode ( + + + ) 2% solution Magnesium acts as a physiological calcium antagonist, producing local vasodilation and muscle relaxation Acute skeletal muscle cramps, localized myofascial trigger points
Hyaluronidase Positive ( + + + ) Anode ( + + + ) 150 U/mL Hydrolyzes hyaluronic acid in the extracellular matrix, accelerating resorption of localized fluid Chronic localized post-traumatic edema, hematoma dispersion
- Contraindications & Safety Precautions
- Absolute Contraindications
Known Drug Allergy or Anaphylactic Hypersensitivity : Administering a drug to which the patient has an allergy (e.g., steroid allergy, hypersensitivity to "caine" local anesthetics, or iodine/seafood allergy for potassium iodide) can trigger severe localized necrosis or systemic anaphylactic shock.
Over Broken, Abraded, or Denuded Skin : Damaged skin loses its electrical resistance. Current will funnel entirely through the abrasion, generating extreme current densities that cause severe focal electrical and chemical burns.
Cardiac Pacemakers or Implantable Cardioverter-Defibrillators (ICDs) : Direct current flow can interfere with sensing leads or trigger dangerous arrhythmias.
Impaired Sensory Discrimination : Patients with diabetic neuropathy, nerve root compression, or spinal trauma who cannot detect burning pain are at high risk for catastrophic skin necrosis.
Active Malignancy in the Treatment Field : Direct current and vasodilation can accelerate tumor angiogenesis or spread malignant cells.
Over Transcranial or Carotid Sinus Regions : Can alter baroreceptor activity, precipitating severe vagal bradycardia or hypotension.
Clinical Execution Best Practices
Do Not Compress Electrodes : Never allow the patient to lie on top of an electrode or secure it with tight elastic wraps. Mechanical pressure collapses capillary perfusion, preventing blood flow from dissipating heat and clearing caustic ions.
Ensure Complete Pad Hydration : Ensure the electrode is fully and evenly saturated with solution. Dry spots create high-resistance zones, causing current to concentrate dangerously into remaining wet areas.